If you’ve been told your low libido is “just stress” or “part of getting older,” you’re not alone—and you’re not wrong to want real solutions. Women experiencing Hypoactive Sexual Desire Disorder (HSDD) now have more treatment options than ever, from FDA-approved medications to innovative compounded formulations like Libida™ from Inner Balance. Understanding how each option works—and what it does for both brain chemistry and emotional connection—can help you find what truly fits your body and your life.
Key Takeaways
- Low libido in women often involves both neurochemical and emotional factors—effective treatment should address desire at its source in the brain, not just physical arousal
- Addyi (flibanserin) is a daily oral pill that takes 4-8 weeks to work and requires avoiding alcohol within 2 hours of your bedtime dose
- Vyleesi (bremelanotide) is an on-demand self-injection that works in 30-60 minutes but carries a 40% nausea rate
- Libida™ combines bremelanotide + oxytocin in a sublingual lozenge—targeting both the dopamine-driven “spark” of desire and the bonding pathways that support emotional readiness
- Libida™ costs approximately $8-$10 per experience, making it an accessible alternative to injectable options
- Hormonal balance matters: For women whose desire feels flat even after addressing hormones, Libida™ works as the “missing piece”—and pairs seamlessly with hormone enrichment therapy like Oestra™
- Delivery method affects results: Sublingual absorption bypasses digestive metabolism and eliminates the need for needles
Libida™ is a brain-based libido booster for women – no hormones, meds, or injections. One dissolvable tablet to bring the spark back, on your terms.
HSA/FSA Eligible •
Free shipping • Cancel anytime
Understanding the Landscape of Female Libido Medications
Hypoactive Sexual Desire Disorder affects a significant number of women, with studies showing prevalence rates ranging from approximately 9% in women aged 20-49 to over 12% in older age groups. It’s characterized by persistently low or absent sexual desire that causes personal distress—not simply a temporary dip related to life circumstances.
For decades, women had few pharmacological options. That changed with the FDA approval of Addyi in 2015 and Vyleesi in 2019. Both medications target brain chemistry rather than physical blood flow (unlike male-focused medications), recognizing that female desire originates in the mind.
Today, women can choose between daily pills, on-demand injections, and sublingual formulations—each with distinct mechanisms, timelines, and trade-offs. The question isn’t just “what works?” but “what works for how women actually experience desire?”
Inner Balance Libida™: The Dual-Pathway Approach
Libida™ represents a new approach to female desire support—one designed specifically around how women’s sexuality actually functions. It’s the first women-first libido solution combining bremelanotide + oxytocin, creating a dual-pathway approach that addresses both the neurochemical spark of wanting and the emotional safety that allows women to relax into intimacy.
How Libida™ Works: Targeting Brain Chemistry and Emotional Connection
Libida™ works through two complementary mechanisms:
Bremelanotide activates melanocortin receptors (MC4R) in the hypothalamus—the brain region that governs motivation and arousal. This boosts dopamine activity, enhancing sexual thoughts, anticipation, and responsiveness. It’s the same FDA-approved active ingredient used in Vyleesi, but delivered without needles.
Oxytocin activates bonding and emotional-safety pathways. Often called the “connection hormone,” oxytocin supports feelings of closeness, relational warmth, and emotional readiness for intimacy. This addresses what many women describe as “I love my partner, but I never feel like it”—the disconnect between emotional affection and physical desire.
The sublingual delivery (a tiny lozenge dissolved under the tongue) allows rapid absorption directly into the bloodstream, bypassing the digestive system entirely. This means faster onset and more predictable effects compared to swallowed tablets.
Key Benefits of Libida™
- On-demand use: Take approximately 45-60 minutes before intimacy—no daily commitment required
- Extended duration: Effects may last 24-72 hours, allowing for natural spontaneity
- Needle-free: Sublingual delivery eliminates injection anxiety and discomfort
- Dual-action formula: The only product addressing both neurochemical desire AND emotional connection pathways
- Non-hormonal: Compatible with any hormonal status—can be used with or without Oestra™ hormone enrichment
- No alcohol restrictions: No required separation from alcohol consumption
- Accessible pricing: Approximately $8-$10 per experience
What Makes Libida™ Different
Women’s desire is complex, involving both the neurochemical “spark” that initiates interest and the emotional context that allows arousal to build. Libida™ is the only formulation that combines both pathways in a single sublingual tablet. The bremelanotide component addresses the dopamine-driven motivation and anticipation of sex, while oxytocin supports the bonding, trust, and emotional openness that women often need to feel genuinely ready for intimacy.
For women who identify with statements like “my spark is gone” or whose hormones are optimized but desire still feels flat, Libida™ offers targeted neurological support that goes beyond what hormone therapy alone can provide.
Who Libida™ Is Best For
Libida™ is specifically designed for:
- Women whose desire feels muted, disconnected, or missing
- Women with HSDD or persistent low libido
- Women who haven’t fully responded to hormone therapy alone
- Women who want a non-hormonal, on-demand, brain-first option
- Women who prefer not to use injections
- Women seeking the emotional connection component alongside neurochemical support
Libida™ is not appropriate during pregnancy, breastfeeding, uncontrolled hypertension, or certain cardiovascular conditions. Inner Balance providers evaluate each patient’s health profile before prescribing.
Cost and Access
Libida™ offers several purchasing options:
- One-time purchase: $249 for 10 tablets
- Monthly subscription: $199/month for 10 tablets
- Best value: $249 for 20 tablets ($279 charged every 2 months)
- Quarterly option: $299 for 30 tablets
At approximately $8-$10 per experience, Libida™ is also HSA/FSA eligible.
Access is simple through Inner Balance’s telehealth platform: complete a brief health assessment, receive physician approval and prescription (typically within 24-48 hours), and have medication shipped directly to your home with ongoing care team support.
Timeline for Results
Libida™ works on-demand. Effects begin approximately 45-60 minutes after taking the sublingual lozenge and may persist for 24-72 hours. Many women report restored fantasies, increased responsiveness, and more satisfying intimate experiences from the first use.
Addyi (Flibanserin): The Daily Pill for Desire
Addyi was the first FDA-approved medication for HSDD, earning approval in 2015 for premenopausal women. Addyi remains FDA-approved for premenopausal women with acquired, generalized HSDD
How Addyi Works: Targeting Brain Chemistry for Desire
Addyi is a serotonin modulator that acts as a 5-HT1A agonist and 5-HT2A antagonist. Unlike medications that affect blood flow, Addyi works in the brain to influence the balance of neurotransmitters—modulating serotonin activity (which can inhibit desire) while increasing dopamine and norepinephrine (which promote it).
It’s taken as a daily oral pill at bedtime. The medication works gradually, with most women needing 4-8 weeks of consistent daily use before noticing meaningful changes in desire.
Practical Considerations
Dosing: One 100mg tablet taken every night at bedtime. This daily commitment is required regardless of whether intimacy is planned.
Alcohol interaction: Women must avoid alcohol within 2 hours of their bedtime dose. The combination of Addyi and alcohol can cause severe hypotension (low blood pressure) and fainting. This was initially a complete contraindication, later adjusted to the 2-hour guideline after post-approval studies.
Side effects: Common effects include dizziness, nausea, and sleepiness. Some women report sleep disruption, including waking in the early morning hours unable to fall back asleep.
Cost: With commercial insurance, costs vary widely depending on coverage. Without insurance, pricing information is available through Addyi’s patient savings programs.
Who Might Consider Addyi
Addyi may suit women who:
- Prefer an oral tablet
- Are comfortable with daily medication commitment
- Can accommodate alcohol restrictions in their lifestyle
- Are patient enough to wait 4-8 weeks for results
- Are postmenopausal (under 65) or premenopausal
Vyleesi (Bremelanotide): The On-Demand Injection for Arousal
Vyleesi received FDA approval in 2019 as the second medication for HSDD in premenopausal women. Unlike Addyi’s daily regimen, Vyleesi is used on-demand—administered when intimacy is anticipated.
How Vyleesi Stimulates Desire: A Brain-Based Approach
Vyleesi contains bremelanotide, a melanocortin receptor agonist that activates MC1R and MC4R receptors in the hypothalamus. This activation increases dopamine and norepinephrine activity, boosting sexual thoughts, motivation, and arousal.
The medication is self-administered via subcutaneous injection (similar to insulin) approximately 45 minutes before anticipated sexual activity. Effects can last up to 24 hours.
Practical Considerations
Administration: Self-injection using an autoinjector pen in the abdomen or thigh.
Frequency limits: Maximum 8 doses per month due to safety monitoring requirements.
No alcohol restrictions: Vyleesi does not interact with alcohol.
Side effects: The most commonly reported effect is nausea—experienced by 40% of clinical trial participants. Other common effects include flushing (20%), headache (11%), and injection site reactions (13%). Some women experience temporary blood pressure elevation.
Hyperpigmentation risk: Approximately 1% of users develop focal skin darkening with repeated use.
Cost: Pricing varies based on insurance coverage. Without insurance, current pricing can be found through pharmacy comparison tools.
Age limitation: Currently approved only for premenopausal women—not for postmenopausal use.
Who Might Consider Vyleesi
Vyleesi may suit women who:
- Prefer on-demand dosing
- Are comfortable with self-injection
- Want to continue drinking alcohol without restrictions
- Are premenopausal
Beyond Medication: Holistic Approaches to Reigniting Female Desire
While medications address neurochemical pathways, desire doesn’t exist in isolation. Lifestyle factors, relationship dynamics, and underlying hormonal status all influence how women experience intimacy.
The Role of Lifestyle in Sexual Wellness
Stress management: Chronic stress elevates cortisol, which directly suppresses sex hormones and desire. Practices like mindfulness, adequate sleep, and boundary-setting can create space for intimacy.
Sleep quality: Poor sleep disrupts hormone production and leaves little energy for connection. Prioritizing 7-9 hours nightly supports both hormonal health and desire.
Movement: Regular physical activity improves blood flow, body confidence, and hormone regulation. Even moderate exercise can meaningfully impact libido over time.
Communication: Sexual satisfaction correlates strongly with relationship communication. Many women find that addressing emotional needs with partners enhances physical desire.
Addressing Underlying Hormonal Imbalances
For many women—especially those in perimenopause or menopause—low libido stems partly from declining estrogen, progesterone, and testosterone. While Libida™ addresses the neurochemical “spark,” optimizing hormonal foundations can create conditions where desire naturally thrives.
Oestra™ Hormone Enrichment Cream provides bioidentical estradiol and progesterone through vaginal delivery, achieving systemic hormone restoration with superior bioavailability. Women report improvements in mood, sleep, energy, and vaginal comfort—all factors that indirectly support healthy desire.
The combination of hormonal optimization (Oestra™) plus targeted desire support (Libida™) represents Inner Balance’s comprehensive approach: address the hormonal foundation while providing neurological amplification when needed.
Making the Right Choice
Choosing a libido medication is deeply personal. What works for one woman may not suit another—and factors like lifestyle, menopausal status, comfort with different delivery methods, and budget all matter.
When comparing options, consider these key differences:
Delivery and timing: Libida™ offers sublingual on-demand dosing with effects in 45-60 minutes lasting 24-72 hours. Addyi requires daily bedtime pills with effects developing over 4-8 weeks. Vyleesi is an on-demand injection with effects in 30-60 minutes lasting up to 24 hours.
Lifestyle compatibility: Libida™ has no alcohol restrictions and requires no injections. Addyi requires avoiding alcohol within 2 hours of your bedtime dose. Vyleesi requires comfort with self-injection but has no alcohol restrictions.
Mechanism of action: Libida™ uniquely combines bremelanotide (for dopamine-driven desire) with oxytocin (for emotional connection). Addyi modulates serotonin to increase dopamine and norepinephrine. Vyleesi uses bremelanotide alone to activate melanocortin receptors.
Menopausal status: Libida™ is compatible with all hormonal statuses. Addyi is approved for premenopausal and postmenopausal women under 65. Vyleesi is approved only for premenopausal women.
Cost considerations: Libida™ costs approximately $8-$10 per experience and is HSA/FSA eligible. Addyi and Vyleesi pricing varies based on insurance coverage.
What’s clear from the research: female desire originates in the brain, not the body. Effective treatments work at the neurochemical level, addressing the motivation and anticipation that initiate wanting. The most comprehensive approaches also acknowledge the emotional dimension—the trust, connection, and safety that allow arousal to build.
For women seeking on-demand support without needles or daily pills, who want both the neurochemical spark and emotional connection pathways addressed, Libida™ offers a unique dual-pathway solution.
If hormonal imbalance is also contributing to symptoms like fatigue, mood changes, sleep disruption, or vaginal dryness, addressing that foundation with bioidentical hormone enrichment may further support desire—and Inner Balance provides both solutions through one integrated care team.
Libida™ is a brain-based libido booster for women – no hormones, meds, or injections. One dissolvable tablet to bring the spark back, on your terms.
HSA/FSA Eligible •
Free shipping • Cancel anytime
Frequently Asked Questions
What is the main difference in how Addyi, Vyleesi, and Libida™ are administered?
Addyi is a daily oral pill taken at bedtime, requiring 4-8 weeks of consistent use. Vyleesi is an on-demand self-injection given 45 minutes before intimacy. Libida™ is an on-demand sublingual lozenge (dissolved under the tongue) taken 45-60 minutes before intimacy—offering on-demand flexibility without needles.
Can Libida™ be used by women who are already on hormone therapy?
Yes. Libida™ is non-hormonal and compatible with any hormonal status. It can be used alongside hormone enrichment therapy like Oestra™ or independently. Many women find that optimizing hormones addresses some desired concerns, while Libida™ provides additional targeted support when needed.
How does Libida™ address both physical and emotional aspects of arousal?
Libida™ combines two active components: bremelanotide activates melanocortin receptors to boost dopamine, motivation, and sexual anticipation (the neurochemical “spark”), while oxytocin supports bonding, emotional safety, and relational warmth. This dual-pathway approach reflects how women’s sexuality actually works—requiring both wanting and emotional readiness.
What are the typical costs associated with these female libido medications?
Addyi and Vyleesi pricing varies based on insurance coverage. Libida™ costs approximately $8-$10 per experience—starting at $199/month on subscription or $249 for a one-time purchase of 10 tablets. Libida™ is also HSA/FSA eligible.
When should a woman consider using a libido medication like Libida™?
Consider Libida™ if your desire feels muted, disconnected, or missing—especially if you identify with phrases like “my spark is gone” or “I love my partner, but I never feel like it.” It’s also appropriate for women who haven’t fully responded to hormone therapy alone, or who want a non-hormonal, on-demand option that addresses both neurochemical desire and emotional connection. Inner Balance offers consultations to help determine if Libida™ is right for your situation.
